Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Selective serotonin receptor uptake inhibitors can reduce restless legs symptoms.

Literature DB >> 10724062

Selective serotonin receptor uptake inhibitors can reduce restless legs symptoms.

S B Dimmitt, G J Riley.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2000 PMID： 10724062 DOI： 10.1001/archinte.160.5.712

Source DB: PubMed Journal: Arch Intern Med ISSN： 0003-9926

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. Restless legs syndrome in an appalachian primary care population: prevalence, demographic and lifestyle correlates, and burden.

Authors: Kim E Innes; Kathryn L Flack; Terry Kit Selfe; Sahiti Kandati; Parul Agarwal
Journal: J Clin Sleep Med Date: 2013-10-15 Impact factor: 4.062

2. Medications associated with restless legs syndrome: a case-control study in the US Renal Data System (USRDS).

Authors: Donald L Bliwise; Rebecca H Zhang; Nancy G Kutner
Journal: Sleep Med Date: 2014-06-13 Impact factor: 3.492

3. "Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome.

Authors: J Winkelmann; M Prager; R Lieb; H Pfister; B Spiegel; H-U Wittchen; F Holsboer; C Trenkwalder; A Ströhle
Journal: J Neurol Date: 2005-01 Impact factor: 4.849

4. Association of Restless Legs Syndrome With Incident Parkinson's Disease.

Authors: Szabolcs Szatmari; Daniel Bereczki; Katalin Fornadi; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Miklos Z Molnar
Journal: Sleep Date: 2017-02-01 Impact factor: 5.849

Review 5. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis.

Authors: Romy Hoque; Andrew L Chesson
Journal: J Clin Sleep Med Date: 2010-02-15 Impact factor: 4.062

Selective serotonin receptor uptake inhibitors can reduce restless legs symptoms.

1. Restless legs syndrome in an appalachian primary care population: prevalence, demographic and lifestyle correlates, and burden.

2. Medications associated with restless legs syndrome: a case-control study in the US Renal Data System (USRDS).

3. "Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome.

4. Association of Restless Legs Syndrome With Incident Parkinson's Disease.

Review 5. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis.

6. Selective serotonin reuptake inhibitors and the risk of restless legs syndrome: a symmetry analysis.

Review 7. [Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment].

8. Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database.